Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line

Auris Nasus Larynx

Volumn 36, Issue 3, 2009, Pages 332-339

  Wang, Rui ^a   Li, Bin ^a   Wang, Xi ^a   Lin, Fang ^a   Gao, Ping ^a   Cheng, Shi Yin ^a   Zhang, Hui Zhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Hep 2; Inhibitors of apoptosis; Radiosensitivity; RNA interference; XIAP

Indexed keywords

SHORT HAIRPIN RNA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CANCER; NICK END LABELING; NUCLEOTIDE SEQUENCE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; LARYNGEAL NEOPLASMS; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 64749095069     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2008.08.006     Document Type: Article

References (30)

1. Zelenin A.V., Kaǐgorodov V.A., and Prasolov V.S. Gene therapy today and tomorrow. Mol Biol (Mosk) 32 (1998) 219-228
2. Hunter A.M., LaCasse E.C., and Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
3. Danson S., Dean E., Dive C., and Ranson M. IAPs as a target for anticancer therapy. Curr Cancer Drug Targets 7 (2007) 785-794
4. Dean E.J., Ranson M., Blackhall F., and Dive C. X-linked inhibitor of apoptosis protein as a therapeutic target. Expert Opin Ther Targets 11 (2007) 1459-1471
5. Eckelman B.P., Salvesen G.S., and Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7 (2006) 988-994
6. Hu Y., Cherton-Horvat G., Dragowska V., Baird S., Korneluk R.G., Durkin J.P., et al. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9 (2003) 2826-2836
7. McManus D.C., Lefebvre C.A., Cherton-Horvat G., St-Jean M., Kandimalla E.R., Agrawal S., et al. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23 (2004) 8105-8117
8. Karagiannis T.C., and El-Osta A. siRNAs: mechanism of RNA interference, in vivo and potential clinical applications. Cancer Biol Ther 3 (2004) 1069-1074
9. Uprichard S.L. The therapeutic potential of RNA interference. FEBS Lett 579 (2005) 5996-6007
10. Hammond S.M., Bernstein E., Beach D., and Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000) 293-296
11. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W.C., et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 99 (2002) 5515-5520
12. Beauvillain de Montreuil C. Malignant tumors of the larynx and the hypopharynx. Epidemiology, diagnosis, treatment. Rev Prat 43 (1993) 631-636
13. Yu H., Xin Y.F., Duan X.D., Zhu L.X., and Jin D.J. Dynamic analysis of epidemiology and etiology on laryngeal carcinoma. Mod Biomed Progr 3 (2007) 393-395 Chinese
14. Zeitels S.M., Blitzer A., Hillman R.E., and Anderson R.R. Foresight in laryngology and laryngeal surgery: a 2020 vision. Ann Otol Rhinol Laryngol Suppl 198 (2007) 2-16
15. Hinerman R.W., Morris C.G., Amdur R.J., Lansford C.D., Werning J.W., Villaret D.B., et al. Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx. Am J Clin Oncol 29 (2006) 613-621
16. Capalbo G., Rödel C., Stauber R.H., Knauer S.K., Bache M., Kappler M., et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol 183 (2007) 593-599
17. Sun J.G., Liao R.X., Chen Z.T., Wang Z.X., Zhang Q., Hu Y.D., et al. Gene transfection of Livin isoforms into A549 cell line and its effect on cell growth and sensitivity to chemotherapy and radiotherapy. Zhonghua Jie He He Hu Xi Za Zhi 28 (2005) 836-840 [in Chinese]
18. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G.S., et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273 (1998) 7787-7790
19. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
20. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., and Wu H. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 104 (2001) 781-790
21. Shiraki K., Sugimoto K., Yamanaka Y., Yamaguchi Y., Saitou Y., Ito K., et al. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med 12 (2003) 705-708
22. Emanuel P.O., Phelps R.G., Mudgil A., Shafir M., and Burstein D.E. Immunohistochemical detection of XIAP in melanoma. J Cutan Pathol 35 (2008) 292-297
23. Nagi C., Xiao G.Q., Li G., Genden E., and Burstein D.E. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma. Ann Diagn Pathol 11 (2007) 402-406
24. Seligson D.B., Hongo F., Huerta-Yepez S., Mizutani Y., Miki T., Yu H., et al. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Clin Cancer Res 13 (2007) 6056-6063
25. Spee B., Jonkers M.D., Arends B., Rutteman G.R., Rothuizen J., and Penning L.C. Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin. Mol Cancer 5 (2006) 34
26. Zhang Y., Wang Y., Gao W., Zhang R., Han X., Jia M., et al. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo. Breast Cancer Res Treat 96 (2006) 267-277
27. Holcik M., Yeh C., Korneluk R.G., and Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19 (2000) 4174-4177
28. Giagkousiklidis S., Vellanki S.H., Debatin K.M., and Fulda S. Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene 26 (2007) 7006-7016
29. Hope I.A. RNAi surges on: application to cultured mammalian cells. Trends Genet 17 (2001) 440
30. Meister G., Landthaler M., Dorsett Y., and Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10 (2004) 544-550